Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes
Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
To determine national prevalence of sodium-glucose contransporter-2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP1RA) use among adults with type 2 diabetes mellitus (T2DM).
We studied adults with T2DM and eGFR ≥ 30 mL/min/1.73 m2 who participated in the cross-sectional National Health and Nutrition Examination Survey (NHAN...
Alternative Titles
Full title
Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2662541361
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2662541361
Other Identifiers
ISSN
1056-8727
E-ISSN
1873-460X
DOI
10.1016/j.jdiacomp.2022.108204
